Alzheimer’s
FDA fast track designation for Biogen’s investigational Alzheimer’s treatment
September 2, 2016Medical Communications, Research and Development Alzheimer's, Alzheimer’s, Biogen, FDA, aducanumab, fast track
Biogen has announced that its investigational Alzheimer’s disease treatment aducanumab has been granted fast track designation by the FDA. The …
Roche dealt with two late-stage blows
December 19, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine
Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …
Otsuka buys Avanir for $3.5 billion
December 3, 2014Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir
Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Alzheimer’s test ‘87% accurate’, say reports
July 9, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Alzheimer’s & dementia, Cameron, NHS, NHS Choices, dementia
NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …
Alzheimer’s disease: pharma’s greatest challenge
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy
Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
Drug giants team up for Alzheimer’s
February 5, 2014Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer
The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
Alzheimer’s research ‘turning point’
October 11, 2013Research and Development, Sales and Marketing Alzheimer's, Alzheimer’s, MRC, research
There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
Biogen Idec buys neurodegenerative disease rights
December 21, 2010Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases
Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
